Sun Pharma Advanced Research Company Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SPARC BSE: 532872
₹197.19
Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #55 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Sun Pharma Advanced Research Company Limited (this stock) 6,399 4.0 116.0% 49.2% — 72 75 66

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹6,955 Cr
EV / EBITDA
4.3x
EV / Sales
3.64x
Market cap / Sales
3.35x
Earnings yield
24.74%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 64 Cr, up 240.7% YoY.

↓ Negative
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs -21 Cr, down 59.7% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 40 -21 -21 ₹-0.6500
March 31, 2026 1,853 1,761 1,761 ₹54.2600
Dec. 31, 2025 8 -81 -81 ₹-2.4800
Sept. 30, 2025 8 -76 -76 ₹-2.3400
June 30, 2025 10 -52 -52 ₹-1.6000
March 31, 2025 27 -61 -61 ₹-1.8800
Dec. 31, 2024 15 -80 -80 ₹-2.4600
Sept. 30, 2024 13 -108 -108 ₹-3.3200
June 30, 2024 17 -97 -97 ₹-2.9800
March 31, 2024 17 -107 -107 ₹-3.2900
Dec. 31, 2023 14 -100 -100 ₹-3.0700
Sept. 30, 2023 21 -86 -86 ₹-2.6600
June 30, 2023 24 -95 -95 ₹-2.9400

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)641,855—819—15131821203034
Operating revenue401,85388102715131717142124
Other income242—09—00246810
Operating expenses74806574628189117112124116113126
Operating profit-341,773-57-66-52-54-74-104-95-108-103-91-102
Operating profit margin-85.9%95.7%-673.0%-838.3%-542.8%-198.3%-498.9%-807.5%-565.9%-649.3%-740.4%-431.9%-426.6%
Depreciation2233333333333
Interest81298653111000
Exceptional items, gain / (loss)——-12——————————
Profit before tax-211,761-81-76-52-61-80-108-97-107-100-86-95
Tax—————————————
Net profit-211,761-81-76-52-61-80-108-97-107-100-86-95
EPS-0.6554.26-2.48-2.34-1.60-1.88-2.46-3.32-2.98-3.29-3.07-2.66-2.94
Net profit (TTM)1,5831,552-270-269-300-345-391-411-390-388-363-254-236
EPS (TTM)48.7947.84-8.30-8.28-9.26-10.64-12.05-12.66-12.00-11.96-11.22-7.78-7.64

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 1,879 1,552 1,552
March 31, 2025 72 -345 -345
March 31, 2024 76 -388 -388
March 31, 2023 239 -223 -223

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) — — ——105†250†145†258†87†196†83†195†
Operating revenue 98.9% 49.3% 1,8797276239137†253†77†183†78†181†
Other income — — ——29†11†7†5†10†14†5†14†
Operating expenses — — 281†399†479†453†324†388†387†334†321†—
Operating profit — — 1,598†-327†-404†-214†-187†-135†-310†-151†-243†—
Operating profit margin — — 85.0%†-456.0%†-534.5%†-89.7%†-136.4%†-53.4%†-403.6%†-82.7%†-309.9%†—
Depreciation — — 10†11†12†12†10†11†9†8†8†—
Interest — — 34†9†2†8†13†11†3†0†0†2†
Exceptional items, gain / (loss) — — -12†0†0†0†0†0†0†0†49†0†
Profit before tax — — 1,552-345-388-223-203†-151†-312†-145†-197†-120†
Tax — — ——————————
Net profit — — 1,552-345-388-223-203†-151†-312†-145†-197†-120†
EPS — — 47.84†-10.64†-11.96†-7.73†-7.72†-5.77†-11.92†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin85.0%†-456.0%†-534.5%†-89.7%†-136.4%†-53.4%†-403.6%†-82.7%†-309.9%†—
EBIT margin84.4%†-468.6%†-511.5%†-90.0%†-138.5%†-55.5%†-403.2%†-79.5%†-251.6%†-65.4%†
PBT margin82.6%-481.0%-513.7%-93.2%-148.2%†-59.7%†-406.7%†-79.5%†-251.7%†-66.4%†
Net margin82.6%-481.0%-513.7%-93.2%-148.2%†-59.7%†-406.7%†-79.5%†-251.7%†-66.4%†
Interest coverage46.49x†-37.75x†-232.80x†-28.17x†-14.26x†-13.19x†-116.00x†-1614.89x†-1640.67x†-65.08x†
Dividend payout——————————
Earnings retention——————————
Current ratio2.46x0.07x————————
Quick ratio2.46x0.07x————————
Debt to equity0.42x—————————
Return on equity116.4%—————————
Return on assets71.6%-104.8%————————
Return on capital employed112.4%†—————————
Asset turnover0.87x0.22x————————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 -239 -24 262 24 -263
March 31, 2025 -362 158 201 10 -373
March 31, 2024 -429 391 43 27 -456
March 31, 2023 -69 -548 617 15 -85
March 31, 2022 -208 -29 229 33 -241

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 2,168 1,334 1,301 556 0 1,861 757 0 85 0
March 31, 2025 329 -221 -253 158 100 25 374 1 95 0
March 31, 2024 — — — — — — — — — —
March 31, 2023 — — — — — — — — — —
March 31, 2022 — — — — — — — — — —

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.